Organ-on-a-chip (OOAC) is an emerging technology based on microfluid platforms and in vitro cell culture that has a promising future in the healthcare industry. The numerous advantages of OOAC over conventional systems make it highly popular. The chip is an innovative combination of novel technologies, including lab-on-a-chip, microfluidics, biomaterials, and tissue engineering. This paper begins by analyzing the need for the development of OOAC followed by a brief introduction to the technology. Later sections discuss and review the various types of OOACs and the fabrication materials used. The implementation of artificial intelligence in the system makes it more advanced, thereby helping to provide a more accurate diagnosis as well as convenient data management. We introduce selected OOAC projects, including applications to organ/disease modelling, pharmacology, personalized medicine, and dentistry. Finally, we point out certain challenges that need to be surmounted in order to further develop and upgrade the current systems.
Machine intelligence methods, including natural language processing, computer vision, machine vision, artificial intelligence, and deep learning approaches, are rapidly evolving and play an essential role in biomedicine. Machine intelligence methods could help to accelerate image analyses aid in building complex models capable of interpretation beyond cognitive limitations and statistical assumptions in biomedicine. However, irrespective of the democratization via accessible computing and software modules, machine intelligence handiness is scarce in the setting of a traditional biomedical research laboratory. In such a context, collaborations with bioinformatics and computational biologists may help. Further, the biomedical diaspora could also seek help from the expert communities using a crowdsourcing website that hosts machine intelligence competitions. Machine intelligence competitions offer a vast pool of seasoned data scientists and machine intelligence experts to develop solutions through competition portals. An alternate approach to improve the adoption of machine intelligence in biomedicine is to offer machine intelligence competitions as part of scientific meetings. In this paper, we discuss a structured methodology employed to develop the machine intelligence competition as part of an international bioinformatics conference. The competition leads to developing a novel method through crowdsourcing to solve a challenging problem in biomedicine – predicting probabilities of proteins that undergo 3D domain swapping. As a biomedical science conference focused on computational methods, the competition received multiple entries that ultimately helped improve the predictive modeling of 3D domain swapping using sequence information.
Tracking and early identification of suspected cases are essential to control and prevent potential COVID-19 outbreaks. One of the most popular techniques used to track this disease is the use of Infrared cameras to identify individuals with elevated body temperatures. However, they are limited by their inability to be implemented in open public settings such as public parks or even outdoor recreational centers. This limits their ability to effectively track possible COVID-19 patients as open public recreational places such as parks, concert venues and other public venues are hotspots for the spreading of the virus. Other technological solutions such as thermal scanners require an individual to perform the actual testing as they are not individual standalone technologies. This method of testing can potentially cause the transmission of the virus between the tester and the individual getting tested. As can be seen, an alternative solution is essential to solving this issue. In this study, we aim to present the system, design and potential scope of a non-invasive system that can diagnose and identify potential COVID-19 patients using thermal and optical images of the individual using drone technology. The proposed system (COVIDRONE) combines multi-modal machine intelligence, computer vision and real-time monitoring to enable scalable monitoring. The system will also involve the use of machine learning algorithms for better and more accurate diagnosis. We envisage that development of such technologies may help in developing technological solutions to combat infectious disease threats in the future pandemics.